Flagellin induces myeloid-derived suppressor cells: Implications for pseudomonas aeruginosa infection in cystic fibrosis lung disease

Journal of Immunology

Volumn 190, Issue 3, 2013, Pages 1276-1284

  Rieber, Nikolaus ^a   Brand, Alina ^a   Hector, Andreas ^a   Graepler Mainka, Ute ^a   Ost, Michael ^a   Schäfer, Iris ^b   Wecker, Irene ^a   Neri, Davide ^a   Wirth, Andreas ^a   Mays, Lauren ^a   Zundel, Sabine ^a   Fuchs, Jörg ^a   Handgretinger, Rupert ^a   Stern, Martin ^a   Hogardt, Michael ^a   Döring, Gerd ^a   Riethmü ller, Joachim ^b   Kormann, Michael ^a   Hartl, Dominik ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; FLAGELLIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TOLL LIKE RECEPTOR 5;

ADOLESCENT; ARTICLE; BACTERIAL FLAGELLUM; BACTERIUM CULTURE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL GROWTH; CELL SURFACE; CELLULAR IMMUNITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTIC FIBROSIS; DISEASE ACTIVITY; EX VIVO STUDY; FEMALE; HOST RESISTANCE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MYELOID DERIVED SUPPRESSOR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PSEUDOMONAS INFECTION; RECEPTOR UPREGULATION; SUPERNATANT; SUPPRESSOR CELL; TH17 CELL;

ADOLESCENT; ADULT; BACTERIAL PROTEINS; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; CYSTIC FIBROSIS; DISEASE SUSCEPTIBILITY; FEMALE; FLAGELLA; FLAGELLIN; GENE EXPRESSION REGULATION; HUMANS; IMMUNE EVASION; IMMUNE TOLERANCE; IMMUNITY, INNATE; LUNG; MALE; MYELOID CELLS; MYELOPOIESIS; PNEUMONIA, BACTERIAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RECEPTORS, CXCR4; T-LYMPHOCYTE SUBSETS; TH17 CELLS; TOLL-LIKE RECEPTOR 5; UP-REGULATION; YOUNG ADULT;

EID: 84872738010     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202144     Document Type: Article

References (50)

1. Zhang, Z., J. P. Louboutin, D. J. Weiner, J. B. Goldberg, and J. M. Wilson. 2005. Human airway epithelial cells sense Pseudomonas aeruginosa infection via recognition of flagellin by Toll-like receptor 5. Infect. Immun. 73: 7151-7160. (Pubitemid 41587612)
2. Hybiske, K., J. K. Ichikawa, V. Huang, S. J. Lory, and T. E. Machen. 2004. Cystic fibrosis airway epithelial cell polarity and bacterial flagellin determine host response to Pseudomonas aeruginosa. Cell. Microbiol. 6: 49-63. (Pubitemid 38111588)
3. Morris, A. E., H. D. Liggitt, T. R. Hawn, and S. J. Skerrett. 2009. Role of Tolllike receptor 5 in the innate immune response to acute P. aeruginosa pneumonia. Am. J. Physiol. Lung Cell. Mol. Physiol. 297: L1112-L1119.
4. Blohmke, C. J., J. Park, A. F. Hirschfeld, R. E. Victor, J. Schneiderman, D. Stefanowicz, M. A. Chilvers, P. R. Durie, M. Corey, J. Zielenski, et al. 2010. TLR5 as an anti-inflammatory target and modifier gene in cystic fibrosis. J. Immunol. 185: 7731-7738.
5. Blohmke, C. J., R. E. Victor, A. F. Hirschfeld, I. M. Elias, D. G. Hancock, C. R. Lane, A. G. Davidson, P. G. Wilcox, K. D. Smith, J. Overhage, et al. 2008. Innate immunity mediated by TLR5 as a novel antiinflammatory target for cystic fibrosis lung disease. J. Immunol. 180: 7764-7773.
6. Cohen, T. S., and A. Prince. 2012. Cystic fibrosis: A mucosal immunodeficiency syndrome. Nat. Med. 18: 509-519.
7. Sorensen, R. U., R. C. Stern, and S. H. Polmar. 1978. Lymphocyte responsiveness to Pseudomonas aeruginosa in cystic fibrosis: Relationship to status of pulmonary disease in sibling pairs. J. Pediatr. 93: 201-205. (Pubitemid 8380028)
8. Sorensen, R. U., R. L. Waller, and J. D. Klinger. 1991. Cystic fibrosis. Infection and immunity to Pseudomonas. Clin. Rev. Allergy 9: 47-74.
9. Youn, J. I., and D. I. Gabrilovich. 2010. The biology of myeloid-derived suppressor cells: The blessing and the curse of morphological and functional heterogeneity. Eur. J. Immunol. 40: 2969-2975.
10. Gabrilovich, D. I., and S. Nagaraj. 2009. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9: 162-174.
11. Ribechini, E., V. Greifenberg, S. Sandwick, and M. B. Lutz. 2010. Subsets, expansion and activation of myeloid-derived suppressor cells. Med. Microbiol. Immunol. (Berl.) 199: 273-281.
12. Gabrilovich, D. I., V. Bronte, S. H. Chen, M. P. Colombo, A. Ochoa, S. Ostrand-Rosenberg, and H. Schreiber. 2007. The terminology issue for myeloid-derived suppressor cells. Cancer Res. 67: 425, author reply 426. (Pubitemid 46142802)
13. Rodriguez, P. C., M. S. Ernstoff, C. P. Hernandez, M. Atkins, J. Zabaleta, R. A. Sierra, and A. C. Ochoa. 2009. Arginase I producing myeloid derived suppressor cells (MDSC) in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res. 69: 1553-1560.
14. Pillay, J., V. M. Kamp, E. van Hoffen, T. Visser, T. Tak, J. W. Lammers, L. H. Ulfman, L. P. Leenen, P. Pickkers, and L. Koenderman. 2012. A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. J. Clin. Invest. 122: 327-336.
15. Brandau, S., S. Trellakis, K. Bruderek, D. Schmaltz, G. Steller, M. Elian, H. Suttmann, M. Schenck, J. Welling, P. Zabel, and S. Lang. 2011. Myeloidderived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties. J. Leukoc. Biol. 89: 311-317.
16. Lechner, M. G., D. J. Liebertz, and A. L. Epstein. 2010. Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells. J. Immunol. 185: 2273-2284.
17. Adamo, R., S. Sokol, G. Soong, M. I. Gomez, and A. Prince. 2004. Pseudomonas aeruginosa flagella activate airway epithelial cells through asialoGM1 and tolllike receptor 2 as well as toll-like receptor 5. Am. J. Respir. Cell Mol. Biol. 30: 627-634. (Pubitemid 38591213)
18. Koller, B., M. Kappler, P. Latzin, A. Gaggar, M. Schreiner, S. Takyar, M. Kormann, M. Kabesch, D. Roos, M. Griese, and D. Hartl. 2008. TLR expression on neutrophils at the pulmonary site of infection: TLR1/TLR2-mediated up-regulation of TLR5 expression in cystic fibrosis lung disease. J. Immunol. 181: 2753-2763.
19. Tseng, J., J. Do, J. H. Widdicombe, and T. E. Machen. 2006. Innate immune responses of human tracheal epithelium to Pseudomonas aeruginosa flagellin, TNF-alpha, and IL-1beta. Am. J. Physiol. Cell Physiol. 290: C678-C690.
20. Pena, J., Z. Fu, C. Schwarzer, and T. E. Machen. 2009. Pseudomonas aeruginosa inhibition of flagellin-activated NF-kappaB and interleukin-8 by human airway epithelial cells. Infect. Immun. 77: 2857-2865.
21. Descamps, D., M. Le Gars, V. Balloy, D. Barbier, S. Maschalidi, M. Tohme, M. Chignard, R. Ramphal, B. Manoury, and J. M. Sallenave. 2012. Toll-like receptor 5 (TLR5), IL-1b secretion, and asparagine endopeptidase are critical factors for alveolar macrophage phagocytosis and bacterial killing. Proc. Natl. Acad. Sci. USA 109: 1619-1624.
22. Ramphal, R., V. Balloy, J. Jyot, A. Verma, M. Si-Tahar, and M. Chignard. 2008. Control of Pseudomonas aeruginosa in the lung requires the recognition of either lipopolysaccharide or flagellin. J. Immunol. 181: 586-592.
23. Ben Mohamed, F., I. Garcia-Verdugo, M. Medina, V. Balloy, M. Chignard, R. Ramphal, and L. Touqui. 2012. A crucial role of Flagellin in the induction of airway mucus production by Pseudomonas aeruginosa. PLoS ONE 7: E39888.
24. Tan, H. L., N. Regamey, S. Brown, A. Bush, C. M. Lloyd, and J. C. Davies. 2011. The Th17 pathway in cystic fibrosis lung disease. Am. J. Respir. Crit. Care Med. 184: 252-258.
25. McAllister, F., A. Henry, J. L. Kreindler, P. J. Dubin, L. Ulrich, C. Steele, J. D. Finder, J. M. Pilewski, B. M. Carreno, S. J. Goldman, et al. 2005. Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogenealpha and granulocyte colony-stimulating factor in bronchial epithelium: Implications for airway inflammation in cystic fibrosis. J. Immunol. 175: 404-412. (Pubitemid 40884344)
26. Dubin, P. J., F. McAllister, and J. K. Kolls. 2007. Is cystic fibrosis a TH17 disease? Inflamm. Res. 56: 221-227.
27. Dubin, P. J., and J. K. Kolls. 2011. IL-17 in cystic fibrosis: More than just Th17 cells. Am. J. Respir. Crit. Care Med. 184: 155-157.
28. Decraene, A., A. Willems-Widyastuti, A. Kasran, K. De Boeck, D. M. Bullens, and L. J. Dupont. 2010. Elevated expression of both mRNA and protein levels of IL-17A in sputum of stable cystic fibrosis patients. Respir. Res. 11: 177.
29. Brodlie, M., M. C. McKean, G. E. Johnson, A. E. Anderson, C. M. U. Hilkens, A. J. Fisher, P. A. Corris, J. L. Lordan, and C. Ward. 2011. Raised interleukin-17 is immunolocalised to neutrophils in cystic fibrosis lung disease. Eur. Respir. J. 37: 1378-1385.
30. Brodlie, M., J. Lordan, and C. Ward. 2011. Can cells other than Th17 lymphocytes be important sources of IL-17 in the lungs? Thorax 66: 1096, author reply 1096-1097.
31. Aujla, S. J., P. J. Dubin, and J. K. Kolls. 2007. Interleukin-17 in pulmonary host defense. Exp. Lung Res. 33: 507-518. (Pubitemid 350256090)
32. Rubin, H. R., R. U. Sorensen, P. A. Chase, and J. D. Klinger. 1983. Suppression of in vitro lymphocyte DNA synthesis by killed Pseudomonas aeruginosa. Infect. Immun. 39: 630-637. (Pubitemid 13188340)
33. Moss, R. B., Y. P. Hsu, and L. Olds. 2000. Cytokine dysregulation in activated cystic fibrosis (CF) peripheral lymphocytes. Clin. Exp. Immunol. 120: 518-525. (Pubitemid 30365559)
34. Kreindler, J. L., C. Steele, N. Nguyen, Y. R. Chan, J. M. Pilewski, J. F. Alcorn, Y. M. Vyas, S. J. Aujla, P. Finelli, M. Blanchard, et al. 2010. Vitamin D3 attenuates Th2 responses to Aspergillus fumigatus mounted by CD4+ T cells from cystic fibrosis patients with allergic bronchopulmonary aspergillosis. J. Clin. Invest. 120: 3242-3254.
35. Hartl, D., M. Griese, M. Kappler, G. Zissel, D. Reinhardt, C. Rebhan, D. J. Schendel, and S. Krauss-Etschmann. 2006. Pulmonary T(H)2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis. J. Allergy Clin. Immunol. 117: 204-211. (Pubitemid 43017162)
36. Moser, C., H. K. Johansen, Z. J. Song, H. P. Hougen, J. Rygaard, and N. Høiby. 1997. Chronic Pseudomonas aeruginosa lung infection is more severe in Th2 responding BALB/c mice compared to Th1 responding C3H/HeN mice. APMIS 105: 838-842. (Pubitemid 27483630)
37. Moser, C., P. O. Jensen, O. Kobayashi, H. P. Hougen, Z. Song, J. Rygaard, A. Kharazmi, and N. H by. 2002. Improved outcome of chronic Pseudomonas aeruginosa lung infection is associated with induction of a Th1-dominated cytokine response. Clin. Exp. Immunol. 127: 206-213. (Pubitemid 34233924)
38. Moser, C., H. P. Hougen, Z. J. Song, J. Rygaard, A. Kharazmi, and N. Høiby. 1999. Early immune response in susceptible and resistant mice strains with chronic Pseudomonas aeruginosa lung infection determines the type of T-helper cell response. APMIS 107: 1093-1100. (Pubitemid 30016634)
39. Dubin, P. J., A. Martz, J. R. Eisenstatt, M. D. Fox, A. Logar, and J. K. Kolls. 2012. Interleukin-23-mediated inflammation in Pseudomonas aeruginosa pulmonary infection. Infect. Immun. 80: 398-409.
40. Dubin, P. J., and J. K. Kolls. 2007. IL-23 mediates inflammatory responses to mucoid Pseudomonas aeruginosa lung infection in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 292: L519-L528.
41. Mueller, C., S. A. Braag, A. Keeler, C. Hodges, M. Drumm, and T. R. Flotte. 2011. Lack of cystic fibrosis transmembrane conductance regulator in CD3+ lymphocytes leads to aberrant cytokine secretion and hyperinflammatory adaptive immune responses. Am. J. Respir. Cell Mol. Biol. 44: 922-929.
42. Moss, R. B. 2010. Allergic bronchopulmonary aspergillosis and Aspergillus infection in cystic fibrosis. Curr. Opin. Pulm. Med. 16: 598-603.
43. Allard, J. B., M. E. Poynter, K. A. Marr, L. Cohn, M. Rincon, and L. A. Whittaker. 2006. Aspergillus fumigatus generates an enhanced Th2-biased immune response in mice with defective cystic fibrosis transmembrane conductance regulator. J. Immunol. 177: 5186-5194. (Pubitemid 44527591)
44. Moss, R. B. 2009. Infection, inflammation, and the downward spiral of cystic fibrosis lung disease. J. Pediatr. 154: 162-163.
45. Moss, R. B. 2004. Lymphocytes in cystic fibrosis lung disease: A tale of two immunities. Clin. Exp. Immunol. 135: 358-360. (Pubitemid 38297135)
46. Hartl, D. 2009. Immunological mechanisms behind the cystic fibrosis-ABPA link. Med. Mycol. 47(Suppl 1): S183-S191.
47. Kelly, E., C. M. Greene, and N. G. McElvaney. 2008. Targeting neutrophil elastase in cystic fibrosis. Expert Opin. Ther. Targets 12: 145-157. (Pubitemid 351284958)
48. Gaggar, A., S.M. Rowe, H. Matthew, and J.E. Blalock. 2010. Proline-glycineproline (PGP) and high mobility group box protein-1 (HMGB1): Potential mediators of cystic fibrosis airway inflammation. Open Respir. Med. J. 4: 32-38.
49. Gaggar, A., Y. Li, N. Weathington, M. Winkler, M. Kong, P. Jackson, J. E. Blalock, and J. P. Clancy. 2007. Matrix metalloprotease-9 dysregulation in lower airway secretions of cystic fibrosis patients. Am. J. Physiol. Lung Cell. Mol. Physiol. 293: L96-L104. (Pubitemid 47080717)
50. Vollbrecht, T., R. Stirner, A. Tufman, J. Roider, R. M. Huber, J. R. Bogner,A. Lechner, C. Bourquin, and R. Draenert. 2012. Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells. AIDS 26: F31-F37.